CV Sciences (CVSI) Net Cash Flow (2011 - 2026)
CV Sciences (CVSI) posted Net Cash Flow of $30000.0 for Q1 2026, up 158.82% sequentially from -$51000.0 in Q4 2025, and down 91.64% YoY from $359000.0 in Q1 2025.
CV Sciences (CVSI) Net Cash Flow (2011 - 2026) Analysis & Trends
CV Sciences has reported Net Cash Flow for 16 years, with the latest figure at $30000.0 in Q1 2026.
- Quarterly Net Cash Flow fell 91.64% year-over-year to $30000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$501000.0 (down 421.15% YoY) and the FY2025 annual result came in at -$172000.0, up 79.93% from the prior year.
- Net Cash Flow grew to $30000.0 in Q1 2026 per CVSI's latest filing, from -$51000.0 in the prior quarter.
- Over five years, Net Cash Flow peaked at $1.1 million in Q1 2022 and troughed at -$1.3 million in Q2 2022.
- A 5-year average of -$62176.5 and a median of -$47000.0 in 2023 frame the typical range for Net Cash Flow.
- The widest YoY moves for Net Cash Flow: up 1168.09% in 2024, down 734.95% in 2024.
- Over 5 years, Net Cash Flow stood at -$528000.0 in 2022, then soared by 38.26% to -$326000.0 in 2023, then sank by 59.82% to -$521000.0 in 2024, then surged by 90.21% to -$51000.0 in 2025, then jumped by 158.82% to $30000.0 in 2026.
- According to Business Quant data, Net Cash Flow over the past three periods registered $30000.0, -$51000.0, and -$551000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | -81.00 Mn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | -458.00 Mn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | -881.03 Mn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 523.50 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -912.40 Mn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 64.40 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 93.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | CV Sciences | 4.10 Mn | 3.84 Mn | 1.45 Mn | -41,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -41,000.00 |
| Jun 30, 2026 | -41,000.00 |
| Mar 31, 2026 | 30,000.00 |
| Mar 31, 2026 | 30,000.00 |
| Dec 31, 2025 | -51,000.00 |
| Dec 31, 2025 | -51,000.00 |
| Sep 30, 2025 | -551,000.00 |
| Sep 30, 2025 | -551,000.00 |
| Jun 30, 2025 | 71,000.00 |
| Jun 30, 2025 | 71,000.00 |
| Mar 31, 2025 | 359,000.00 |
| Mar 31, 2025 | 359,000.00 |
| Dec 31, 2024 | -521,000.00 |
| Dec 31, 2024 | -521,000.00 |
| Sep 30, 2024 | 502,000.00 |
| Sep 30, 2024 | 502,000.00 |
| Jun 30, 2024 | -184,000.00 |
| Jun 30, 2024 | -184,000.00 |
| Mar 31, 2024 | -654,000.00 |
| Mar 31, 2024 | -654,000.00 |